SOLACI Research | Latin American Registry of Percutaneous Interventions in Coronary Bifurcations – LATAM Bif Registry.

We have the honor to invite you to participate in the Latin American Registry of Percutaneous Interventions in Coronary Bifurcations – LATAM Bif Registry.

Coronary bifurcations represent a field of particular interest in interventional cardiology, representing 15-20% of coronary angioplasties performed in our daily practice.

The LATAM Bif Registry is the scientific research program of the Latin American Society of Interventional Cardiology (SOLACI) and the LATAM Bifurcation Club. It is a multicenter and prospective registry, open to all Latin American centers eager to participate. It seeks to evaluate the reality of bifurcation PCI, to better define our needs and establish the best strategies to perfect our daily practice.

Learn about the structure of the LATAM BIF registry in the following video:

video LATAM Bif

The benefits of participating

  1. Access our own database dedicated to coronary bifurcations, with unified criteria across Latin American centers.
  2. Analyze outcomes in real time with data from your own center.
  3. Interact with centers across the region interested in promoting research and furthering publishing.
  4. Present LATAM Bif outcomes at local and international events.
  5. Benefit from SOLACI Research assistance to develop your research projects and/or statistical analysis. 
  6. Work closely with SOLACI Research, who will oversee your progress weekly and will make sure all data be used correctly from start to finish, with annual (mandatory) followup.

SOLACI and all LATAM Bif Registry members would be honored to count on all member societies and their support to this important initiative.

To take part of LATAM Bif Registry, please email us to latambif@gmail.com

Sincerely,

Latam Bif - firmas


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....